AGEC 608 Lecture 17, p. 1 AGEC 608: Lecture 17 Objective: Review the main aspects of cost- effectiveness analysis (CEA) and cost-utility analysis (CUA).

Slides:



Advertisements
Similar presentations
ECONOMIC EVALUATION WHY DO YOU NEED TO BOTHER? JUDITH BOSMANS.
Advertisements

Hawawini & VialletChapter 7© 2007 Thomson South-Western Chapter 7 ALTERNATIVES TO THE NET PRESENT VALUE RULE.
Capital Budgeting Last Update Copyright Kenneth M. Chipps Ph.D
© Harry Campbell & Richard Brown School of Economics The University of Queensland BENEFIT-COST ANALYSIS Financial and Economic Appraisal using Spreadsheets.
Issues in Capital Budgeting II
We show that MP can be used to allocate resources to treatments within and between patient populations, using a policy-relevant example. The outcome is.
Ch 6 Project Analysis Under Certainty
Economic Analysis Concepts. 2 Is the project justified ?- Are benefits greater than costs? Which is the best investment if we have a set of mutually exclusive.
A METHODOLOGY FOR MEASURING THE COST- UTILITY OF EARLY CHILDHOOD DEVELOPMENTAL INTERVENTIONS Quality of improved life opportunities (QILO)
Managerial Economics and Organizational Architecture, 5e Chapter 17: Divisional Performance Evaluation McGraw-Hill/Irwin Copyright © 2009 by The McGraw-Hill.
Economic evaluation considers assessment of intervention effects in economic terms, which is often of greatest interest to fund allocators Intervention.
1 Extreme Events Cost-Effectiveness Analysis Scott Matthews Courses: /
Arda ÇELİK DEÜ Endüstri Mühendisliği ABSTRACT Cost analysis can play strategic roles in organizations and plans. As industrial engineers,
(c) 2001 Contemporary Engineering Economics 1 Chapter 17 Economic Analysis in the Public Sector Framework of Benefit- Cost Analysis Valuation of Benefits.
1 Cost-Effectiveness Analysis Life Years Analysis Scott Matthews Courses: /
1 Civil Systems Planning Benefit/Cost Analysis Scott Matthews Courses: and Lecture /4/2002.
317_L25, Mar J. Schaafsma 1 Review of the Last Lecture Have discussed three methods for shadow pricing life and limb for CBA: human capital method,
AGEC 608 Lecture 11, p. 1 AGEC 608: Lecture 11 Objective: Provide overview of how “demonstrations” are typically used in deriving benefits and costs of.
COST–EFFECTIVENESS ANALYSIS AND COST-UTILITY ANALYSIS
AGEC 608 Lecture 02, p. 1 AGEC 608: Lecture 2 Objective: Review conceptual foundations of CBA Readings: –Boardman, Chapter 2 –Kankakee, Sections I and.
Health care decision making Dr. Giampiero Favato presented at the University Program in Health Economics Ragusa, June 2008.
1 Cost-Effectiveness Analysis (CEA) Scott Matthews Courses: and Lecture /3/2003.
1 Cost-Utility Analysis Cost-Effectiveness Analysis Scott Matthews Courses: / / Lecture /9/2005.
POST- RANDOMIZATION DATA ANALYSIS OGNEN JAKASANOVSKI
Chapter 4: Economic Efficiency and Cost Benefit Analysis 1.Economic Efficiency 2.Cost Benefit Analysis.
Health Economics & Policy 3 rd Edition James W. Henderson Chapter 4 Economic Evaluation in Health Care.
Economic Evaluations, Briefly… CHSC 433 Module 6/Chapter 13 UIC School of Public Health L. Michele Issel, PhD, R N.
Cost-Effectiveness Problem l You have a $1.5 billion budget to spend on any combination of these programs:
CENTRE FOR HEALTH ECONOMICS AND DEVELOPEMNT ESTIMATING ECONOMIC AND FISCAL IMPACT OF HEALTH AND NON HEALTH EXPENDITURE FROM THE NATIONAL HEALTH BILL Kenneth.
Chapter One The Central Idea. 1 | 2 Copyright © Houghton Mifflin Company. All rights reserved. Economics and Scarcity Economics is the study of how people.
Hawawini & VialletChapter 71 ALTERNATIVES TO THE NPV RULE.
Outcomes based approach to measuring the impact of new technology Vikas Arya HSCI 740 Spring 2004 May 22,2004.
Knowing what you get for what you pay An introduction to cost effectiveness FETP India.
IN THE NAME OF GOD Flagship Course on Health Sector Reform and Sustainable Financing; Module 4: : How to construct.
Evaluating the Options Analyst’s job is to: gather the best evidence possible in the time allowed to compare the potential impacts of policies.
Cost-Effectiveness Thresholds Professor of Health Economics
Economic evaluation Definition - the comparative analysis of alternative courses of action in terms of both their cost and consequences.
317_L26, Mar J. Schaafsma 1 Review of the Last Lecture Are looking at program evaluation in healthcare Three methods: CBA, CEA, CUA discussed CBA,
Phaedra Corso, Ph.D. Associate Professor College of Public Health University of Georgia Program Evaluation from an Economic Perspective.
انواع ارزيابي های اقتصادي سيدرضا مجدزاده مرکز تحقيقات بهره برداری از دانش سلامت و دانشکده بهداشت دانشگاه علوم پزشکي و خدمات بهداشتي درماني تهران.
CAPITAL BUDGETING_LECT 091 The Concept of Opportunity Cost The concept of opportunity cost is used in CBA to place a dollar value on the inputs required.
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 23: Nov 17, 2008.
Sample Size Determination in Studies Where Health State Utility Assessments Are Compared Across Groups & Time Barbara H Hanusa 1,2 Christopher R H Hanusa.
Make Nutrition Services Count: Cost-Effectiveness Research & Outcomes Research.
PHARMACOECONOMICS Dr. Mohammad Aljawadi, PharmD PhD Department of Clinical Pharmacy King Saud University Aug, 2015 PHCL 431.
Copyright © 2009 Pearson Addison-Wesley. All rights reserved. Chapter 3 Valuing the Environment: Methods.
PHARMAC What is PHARMAC? PHARMAC - the Pharmaceutical Management AgencyPHARMAC - the Pharmaceutical Management Agency A New Zealand Government Agency (Crown.
Flagship Program on Health Sector Reform and Sustainable Financing.
Benefit: Cost Ratio David Pannell School of Agricultural and Resource Economics University of Western Australia.
WHAT IS THE ROLE OF ECONOMICS IN THE WFD PROCESS? A selection of key economic inputs.
Cost-Effectiveness and Outcomes Research Setting value to what we do.
Benefit-Cost Analysis in Environmental Decision Making
Towards an Agenda for Measuring Efficiency in Health Care Michael Chernew Sept. 27, 2007.
CRJS 4466 PROGRAM & POLICY EVALUATION LECTURE #6 Evaluation projects Questions?
© University of South Wales Royal College of Speech and Language Therapists Outcomes Conference and Hub Launch Belfast, May 1, 2014 Running a tight ship:
BENEFIT-COST ANALYSIS Financial and Economic Appraisal using Spreadsheets Ch. 3: Decision Rules © Harry Campbell & Richard Brown School of Economics The.
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 7: Cost-effectiveness analysis – Part.
Chapter 6 PRODUCTION. CHAPTER 6 OUTLINE 6.1The Technology of Production 6.2Production with One Variable Input (Labor) 6.3Production with Two Variable.
Analysis Manager Training Module
Lecture 15 Assoc. Prof. Sencer Ecer HEALTH ECONOMICS
Introduction to Economics of Water Resources Lecture 5
Yale Braunstein School of Information Management & Systems
Economics of Public Health Nursing
6. Discounting Reading: BGVW, Chapters 6.
Health care decision making
Sergio Bautista-Arredondo National Institute of Public Health Mexico
Marginal Analysis for Optimal Decision Making
Assessing value for money: principles, methods and issues
Measuring outcomes Emma Frew October 2012.
Presentation Developed for the Academy of Managed Care Pharmacy
Presentation transcript:

AGEC 608 Lecture 17, p. 1 AGEC 608: Lecture 17 Objective: Review the main aspects of cost- effectiveness analysis (CEA) and cost-utility analysis (CUA). Readings: –Boardman, Chapter 17 Homework #5: Chapter 13, problem 3 Chapter 14, problem 3 Chapter 17, problem 1 due: next class - April 24

AGEC 608 Lecture 17, p. 2 Cost-effectiveness analysis Cost effectiveness analysis (CEA) compares (mutually exclusive) alternatives on the basis of the ratio of their costs and a single (but not monetized) effectiveness measure. Most useful when outcomes can be quantified but not easily converted to dollar terms.

AGEC 608 Lecture 17, p. 3 Cost-utility analysis Cost-utility analysis (CUA) usually relates costs to a benefit construct consisting of (usually two) benefit categories reflecting both quantity and quality. Again, most useful when outcomes can be quantified but not easily converted to dollar terms, and where outcomes have both a quantity and quality aspect: Example: length and quality of life quality-adjusted life years (QALY) CUA is closer to CBA than CEA

AGEC 608 Lecture 17, p. 4 Cost-effectiveness analysis CEA involves two metrics: cost measure of effectiveness As a result, one cannot obtain a single measure of social net benefit, only the ratio of the two. Two approaches: CE i = C i /E i (avg cost per unit of effectiveness) smaller is better EC i = E i /C i (avg effectiveness per unit cost) larger is better

AGEC 608 Lecture 17, p. 5 Cost-effectiveness analysis CEA is a measure of technical efficiency: ratio of input to output, or ratio of output to input Not a good measure of allocative efficiency: “is this the best use of scarce resources?”

AGEC 608 Lecture 17, p. 6 Measurement of costs Measures of costs in CEAs are highly variable. Although it is preferable to include all social costs in a CEA, the costs that are constant across alternatives will not change the rankings, only the CE ratio. CEA may not give the same ranking as CBA.

AGEC 608 Lecture 17, p. 7 Omitted impacts Most CEAs only include “budgetary” costs. CEA considers only one measure of effectiveness, but some interventions may have multiple impacts. Example: new drug development may save lives and also produce fewer side effects. Adjusted CE ratio: ACE = social costs – other social benefits effectiveness

AGEC 608 Lecture 17, p. 8 Scale issues CEAs do not take into account different scales of projects If all alternatives have the same cost, or if all alternatives have the same level of effectiveness, then this will not matter. But if scales differ, it is impossible to say which project is best. See Table 17.3

AGEC 608 Lecture 17, p. 9 Constraints in CEA One way to account for scale in a CEA is to impose a constraint on the project, e.g. maximum cost or minimum effectiveness. Alternatives: Minimize cost subject to effectiveness target Maximize effectiveness subject to budget constraint See Table 17.4

AGEC 608 Lecture 17, p. 10 Cost-utility Analysis Most often used in the area of health care Common measure of effectiveness: quality-adjusted life years (QALY) QALY combines notion of health status (quality) and years of life (quantity) Ambiguities still arise: see Table 17.5

AGEC 608 Lecture 17, p. 11 QALY Three common approaches: 1. Health rating method experts or others assign scores 0-1 to various states 2. Time trade-off method respondents rank length and quality of life combinations 3. Standard gamble method decision tree with alternatives (see Figure 17.2)

AGEC 608 Lecture 17, p. 12 Caveats on CUA Two main problems: 1. Discounting is problematic can’t tradeoff health now and later 2. Methods are based on questionnaires sample selection, framing bias, etc.

AGEC 608 Lecture 17, p. 13 Phamacoeconomics Use of economic methods to evaluate pharmaceutical products. Amount spent on drug development is large and growing… Funds for drug development are often public funds… How to decide how to allocate scarce resources? CEA and CUA often used.

AGEC 608 Lecture 17, p. 14 League Tables CEA and CUA usually compare mutually exclusive alternatives (drug A vs. drug B) How to compare non-exclusive alternatives? (e.g. policies aimed at saving lives in general) League tables rank multiple CEAs or CUAs that share a common cost-effectiveness measure. They can be used to compare investments in different kinds of health treatments. Cost per life saved (Morrall): steering column regulation ($160,000) cattle feed regulation ($212 Million)

AGEC 608 Lecture 17, p. 15 CEA vs CBA CEA does not measure allocative efficiency CEA is closest to CBA when: 1. All social costs are included 2. The measure of effectiveness capture all benefits 3. Alternative projects are of similar scales